Sagimet Biosciences Inc. Series A Common Stock (SGMT) Insider Trading
- $1,295,153.50
- $1,021,921.78
- Feb. 10, 2026
- David Happel
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Feb. 10, 2026 | CFO | 1,312 | $5.36 | Sell | $7,032.32 | |
| Feb. 10, 2026 | CEO | 12,101 | $5.36 | Sell | $64,861.36 | |
| July 21, 2025 | Insider | 8,277 | $9.13 | Sell | $75,569.01 | |
| July 21, 2025 | General Counsel | 10,780 | $9.13 | Sell | $98,421.40 | |
| July 21, 2025 | CEO | 65,478 | $9.13 | Sell | $597,814.14 | |
| July 23, 2024 | Chairman | 23,625 | $3.17 | Sell | $74,891.25 | |
| July 19, 2024 | General Counsel | 10,914 | $3.10 | Sell | $33,833.40 | |
| July 19, 2024 | Insider | 8,357 | $3.10 | Sell | $25,906.70 | |
| July 19, 2024 | Chairman | 14,062 | $3.10 | Sell | $43,592.20 | |
| March 26, 2024 | CEO | 12,100 | $5.27 | Buy | $63,767.00 | |
| Nov. 16, 2023 | CEO | 590 | $2.35 | Buy | $1,386.50 | |
| July 18, 2023 | Director | 46,875 | $16.00 | Buy | $750,000.00 | |
| July 18, 2023 | Major Shareholder | 30,000 | $16.00 | Buy | $480,000.00 |
Insiders are both buying and selling Sagimet Biosciences Inc. Series A Common Stock stock.
The insider traders at Sagimet Biosciences Inc. Series A Common Stock are: David Happel, Eduardo Bruno Martins, Elizabeth Rozek, George Kemble, Enterprise Associates 13 L New, Thierry Chauche, and Beth C Seidenberg
The most active insider trader at Sagimet Biosciences Inc. Series A Common Stock is David Happel with 4 trades.
David Happel has sold the most Sagimet Biosciences Inc. Series A Common Stock stock with a total value of $727,536.86.
Beth C Seidenberg has bought the most Sagimet Biosciences Inc. Series A Common Stock stock with a total value of $1,500,000.00.
The most recent insider trade for Sagimet Biosciences Inc. Series A Common Stock was on Feb. 10, 2026.
The single biggest insider buy for Sagimet Biosciences Inc. Series A Common Stock was from Beth C Seidenberg with a total value of $750,000.00 on July 18, 2023.
The single biggest insider sell for Sagimet Biosciences Inc. Series A Common Stock was from David Happel with a total value of $597,814.14 on July 21, 2025.